- Home
- COE vs CTMX Comparison
COE vs CTMX Comparison
Compare COE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- CTMX
- Stock Information
- Founded
- COE 2011
- CTMX 2008
- Country
- COE Singapore
- CTMX United States
- Employees
- COE N/A
- CTMX N/A
- Industry
- COE Other Consumer Services
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- COE Real Estate
- CTMX Health Care
- Exchange
- COE Nasdaq
- CTMX Nasdaq
- Market Cap
- COE 117.5M
- CTMX 444.3M
- IPO Year
- COE 2016
- CTMX 2015
- Fundamental
- Price
- COE $30.01
- CTMX $2.48
- Analyst Decision
- COE
- CTMX Strong Buy
- Analyst Count
- COE 0
- CTMX 2
- Target Price
- COE N/A
- CTMX $5.00
- AVG Volume (30 Days)
- COE 24.1K
- CTMX 2.7M
- Earning Date
- COE 06-09-2025
- CTMX 08-07-2025
- Dividend Yield
- COE N/A
- CTMX N/A
- EPS Growth
- COE N/A
- CTMX 128.27
- EPS
- COE N/A
- CTMX 0.49
- Revenue
- COE $59,490,000.00
- CTMX $147,557,000.00
- Revenue This Year
- COE N/A
- CTMX N/A
- Revenue Next Year
- COE N/A
- CTMX N/A
- P/E Ratio
- COE N/A
- CTMX $5.11
- Revenue Growth
- COE 91.87
- CTMX 23.81
- 52 Week Low
- COE $10.52
- CTMX $0.40
- 52 Week High
- COE $34.74
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- COE 60.55
- CTMX 56.59
- Support Level
- COE $25.75
- CTMX $2.15
- Resistance Level
- COE $34.74
- CTMX $2.44
- Average True Range (ATR)
- COE 2.20
- CTMX 0.24
- MACD
- COE -0.20
- CTMX -0.05
- Stochastic Oscillator
- COE 47.40
- CTMX 39.71
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.